Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,908 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.
Komatsu H, Matsumoto K, Morita M, Nagasawa T, Nishio H, Suzuki J, Nishio S, Kobara H, Yunokawa M, Ariyoshi K, Hirayama T, Tokunaga H, Ukita M, Yoriki K, Mori-Uchino M, Furusawa A, Togami S, Nakamura H, Ishikawa M, Satoh T. Komatsu H, et al. Among authors: ishikawa m. Cancer Med. 2024 Mar;13(5):e6968. doi: 10.1002/cam4.6968. Cancer Med. 2024. PMID: 38491829 Free PMC article.
A non-randomized confirmatory study regarding selection of fertility-sparing surgery for patients with epithelial ovarian cancer: Japan Clinical Oncology Group Study (JCOG1203).
Satoh T, Tsuda H, Kanato K, Nakamura K, Shibata T, Takano M, Baba T, Ishikawa M, Ushijima K, Yaegashi N, Yoshikawa H; Gynecologic Cancer Study Group of the Japan Clinical Oncology Group. Satoh T, et al. Among authors: ishikawa m. Jpn J Clin Oncol. 2015 Jun;45(6):595-9. doi: 10.1093/jjco/hyv032. Epub 2015 Mar 25. Jpn J Clin Oncol. 2015. PMID: 26059697
Baseline risk of recurrence in stage I-II endometrial carcinoma.
Sasada S, Yunokawa M, Takehara Y, Ishikawa M, Ikeda S, Kato T, Tamura K. Sasada S, et al. Among authors: ishikawa m. J Gynecol Oncol. 2018 Jan;29(1):e9. doi: 10.3802/jgo.2018.29.e9. J Gynecol Oncol. 2018. PMID: 29185267 Free PMC article.
A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent or persistent cervical carcinoma: Japan Clinical Oncology Group Study (JCOG1311).
Ishikawa M, Nakamura K, Shibata T, Tanaka K, Kitagawa R, Kobayashi H, Yaegashi N; Gynecologic Cancer Study Group of the Japan Clinical Oncology Group. Ishikawa M, et al. Jpn J Clin Oncol. 2018 Dec 1;48(12):1096-1100. doi: 10.1093/jjco/hyy137. Jpn J Clin Oncol. 2018. PMID: 30295796 Clinical Trial.
3,908 results